Literature DB >> 10817712

Experimental induction of fluconazole resistance in Candida tropicalis ATCC 750.

F Barchiesi1, D Calabrese, D Sanglard, L Falconi Di Francesco, F Caselli, D Giannini, A Giacometti, S Gavaudan, G Scalise.   

Abstract

Candida tropicalis is less commonly isolated from clinical specimens than Candida albicans. Unlike C. albicans, which can be occasionally found as a commensal, C. tropicalis is almost always associated with the development of fungal infections. In addition, C. tropicalis has been reported to be resistant to fluconazole (FLC). To analyze the development of FLC resistance in C. tropicalis, an FLC-susceptible strain (ATCC 750) (MIC = 1.0 microg/ml) was cultured in liquid medium containing increasing FLC concentrations from 8.0 to 128 microg/ml. The strain developed variable degrees of FLC resistance which paralleled the concentrations of FLC used in the medium. The highest MICs of FLC were 16, 256, and 512 microg/ml for strains grown in medium with 8.0, 32, and 128 microg of FLC per ml, respectively. Development of resistance was rapid and could be observed already after a single subculture in azole-containing medium. The resistant strains were cross-resistant to itraconazole (MIC > 1.0 microg/ml) and terbinafine (MIC > 512 microg/ml) but not to amphotericin B. Isolates grown in FLC at concentrations of 8.0 and 32 microg/ml reverted to low MICs (1.0 microg/ml) after 12 and 11 passages in FLC-free medium, respectively. The MIC for one isolate grown in FLC (128 microg/ml) (128 R) reverted to 16 microg/ml but remained stable over 60 passages in FLC-free medium. Azole-resistant isolates revealed upregulation of two different multidrug efflux transporter genes: the major facilitators gene MDR1 and the ATP-binding cassette transporter CDR1. The development of FLC resistance in vitro correlated well with the results obtained in an experimental model of disseminated candidiasis. While FLC given at 10 mg/kg of body weight/day was effective in reducing the fungal burden of mice infected with the parent strain, the same dosing regimen was ineffective in mice infected with strain 128 R. Finally, the acquisition of in vitro FLC resistance in strain 128 R was related to a loss of virulence. The results of our study elucidate important characteristics and potential mechanisms of FLC resistance in C. tropicalis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10817712      PMCID: PMC89916          DOI: 10.1128/AAC.44.6.1578-1584.2000

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  38 in total

1.  Optimizing the correlation between results of testing in vitro and therapeutic outcome in vivo for fluconazole by testing critical isolates in a murine model of invasive candidiasis.

Authors:  J H Rex; P W Nelson; V L Paetznick; M Lozano-Chiu; A Espinel-Ingroff; E J Anaissie
Journal:  Antimicrob Agents Chemother       Date:  1998-01       Impact factor: 5.191

2.  Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole.

Authors:  J R Wingard; W G Merz; M G Rinaldi; T R Johnson; J E Karp; R Saral
Journal:  N Engl J Med       Date:  1991-10-31       Impact factor: 91.245

3.  In-vitro activity of five antifungal agents against uncommon clinical isolates of Candida spp.

Authors:  F Barchiesi; A M Tortorano; L F Di Francesco; M Cogliati; G Scalise; M A Viviani
Journal:  J Antimicrob Chemother       Date:  1999-02       Impact factor: 5.790

Review 4.  Oral azole drugs as systemic antifungal therapy.

Authors:  J A Como; W E Dismukes
Journal:  N Engl J Med       Date:  1994-01-27       Impact factor: 91.245

5.  Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients.

Authors:  J R Wingard; W G Merz; M G Rinaldi; C B Miller; J E Karp; R Saral
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

6.  The lipid composition of azole-sensitive and azole-resistant strains of Candida albicans.

Authors:  C A Hitchcock; K J Barrett-Bee; N J Russell
Journal:  J Gen Microbiol       Date:  1986-09

7.  Isolation of the Candida tropicalis gene for P450 lanosterol demethylase and its expression in Saccharomyces cerevisiae.

Authors:  C Chen; T G Turi; D Sanglard; J C Loper
Journal:  Biochem Biophys Res Commun       Date:  1987-08-14       Impact factor: 3.575

8.  Characterization of an azole-resistant Candida glabrata isolate.

Authors:  H vanden Bossche; P Marichal; F C Odds; L Le Jeune; M C Coene
Journal:  Antimicrob Agents Chemother       Date:  1992-12       Impact factor: 5.191

Review 9.  Resistance of yeasts to azole-derivative antifungals.

Authors:  F C Odds
Journal:  J Antimicrob Chemother       Date:  1993-04       Impact factor: 5.790

10.  Variations in fluconazole susceptibility and electrophoretic karyotype among oral isolates of Candida albicans from patients with AIDS and oral candidiasis.

Authors:  M A Pfaller; J Rhine-Chalberg; S W Redding; J Smith; G Farinacci; A W Fothergill; M G Rinaldi
Journal:  J Clin Microbiol       Date:  1994-01       Impact factor: 5.948

View more
  36 in total

1.  The effect of cumulative length of hospital stay on the antifungal resistance of Candida strains isolated from critically ill surgical patients.

Authors:  Themistoklis K Kourkoumpetis; George C Velmahos; Panayiotis D Ziakas; Emmanouil Tampakakis; Dimitra Manolakaki; Jeffrey J Coleman; Eleftherios Mylonakis
Journal:  Mycopathologia       Date:  2010-10-08       Impact factor: 2.574

2.  Transcriptional profiling of azole-resistant Candida parapsilosis strains.

Authors:  A P Silva; I M Miranda; A Guida; J Synnott; R Rocha; R Silva; A Amorim; C Pina-Vaz; G Butler; A G Rodrigues
Journal:  Antimicrob Agents Chemother       Date:  2011-04-25       Impact factor: 5.191

3.  Cell Wall Changes in Amphotericin B-Resistant Strains from Candida tropicalis and Relationship with the Immune Responses Elicited by the Host.

Authors:  Ana C Mesa-Arango; Cristina Rueda; Elvira Román; Jessica Quintin; María C Terrón; Daniel Luque; Mihai G Netea; Jesus Pla; Oscar Zaragoza
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

4.  Impact of antimicrobial dosing regimen on evolution of drug resistance in vivo: fluconazole and Candida albicans.

Authors:  D Andes; A Forrest; A Lepak; J Nett; K Marchillo; L Lincoln
Journal:  Antimicrob Agents Chemother       Date:  2006-07       Impact factor: 5.191

Review 5.  Mechanisms of Antifungal Drug Resistance.

Authors:  Leah E Cowen; Dominique Sanglard; Susan J Howard; P David Rogers; David S Perlin
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-10       Impact factor: 6.915

6.  Mechanisms of azole resistance in a clinical isolate of Candida tropicalis.

Authors:  Patrick Vandeputte; Gérald Larcher; Thierry Bergès; Gilles Renier; Dominique Chabasse; Jean-Philippe Bouchara
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

7.  Azole resistance in Candida glabrata: coordinate upregulation of multidrug transporters and evidence for a Pdr1-like transcription factor.

Authors:  John-Paul Vermitsky; Thomas D Edlind
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

8.  Candida parapsilosis Resistance to Fluconazole: Molecular Mechanisms and In Vivo Impact in Infected Galleria mellonella Larvae.

Authors:  Ana Carolina R Souza; Beth Burgwyn Fuchs; Henrique M S Pinhati; Ricardo A Siqueira; Ferry Hagen; Jacques F Meis; Eleftherios Mylonakis; Arnaldo L Colombo
Journal:  Antimicrob Agents Chemother       Date:  2015-08-10       Impact factor: 5.191

9.  Increase in resistance to fluconazole and itraconazole in Trichophyton rubrum clinical isolates by sequential passages in vitro under drug pressure.

Authors:  Anita Hryncewicz-Gwóźdź; Katarzyna Kalinowska; Ewa Plomer-Niezgoda; Jacek Bielecki; Tomasz Jagielski
Journal:  Mycopathologia       Date:  2013-04-18       Impact factor: 2.574

10.  Synergistic effects of amiodarone and fluconazole on Candida tropicalis resistant to fluconazole.

Authors:  Cecília Rocha da Silva; João Batista de Andrade Neto; José Júlio Costa Sidrim; Maria Rozzelê Ferreira Angelo; Hemerson Iury Ferreira Magalhães; Bruno Coêlho Cavalcanti; Raimunda Sâmia Nogueira Brilhante; Danielle Silveira Macedo; Manoel Odorico de Moraes; Marina Duarte Pinto Lobo; Thalles Barbosa Grangeiro; Hélio Vitoriano Nobre Júnior
Journal:  Antimicrob Agents Chemother       Date:  2013-01-28       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.